Investing in mRNA Technologies
David Maza, Managing Director and Head of Product at Direxion, joins Cheddar News to discuss the evolution of mRNA technologies, future applications of this tech including fighting Lyme disease and HIV, and what this all means for investors.
More Videos
The Fabric of Success: BrilliA’s CEO on Innovation, IPO, and Market Leadership
Kendrew Hartanto, CEO of BrilliA (NYSE: BRIA), shares how the company stitched its path to IPO and redefined leadership in women’s undergarments.
Go Fund Yourself: From Spirited Sips to Smart Learning
Hook Hand Rum elevates your drinking experience with its very own handcrafted rum. Illoominate encourages learning and creativity for kids using AI.
The Man Studios Listen To: Kevin Goetz on Testing 3,000+ Films at Screen Engine
Kevin Goetz, CEO of Screen Engine, shares how testing 3,000+ films—including Barbie—helps studios shape stories audiences love.
Scaling Prefab with AI: Dextall CEO Aurimas Sabulis Tackles Housing Crisis
Aurimas Sabulis, CEO of Dextall, unveils how AI‑driven prefabricated façades slash design time by 80%, labor by 87%, and accelerate affordable housing delivery.
Home Prices Continue to Rise Despite Declining Sales
U.S. home sales slowed to their weakest pace in nearly 14 years, with rising mortgage rates and affordability concerns affecting market activity.
Jobs Report Underwhelms as Job Growth Stalls
Mark Hamrick of Bankrate helps make sense of the jobs report despite inflation but warns that uncertainty around tariffs could disrupt growth.
